View More View Less
  • 1 Heart Center, Semmelweis University, Budapest, Hungary
  • 2 National Heart and Lung Institute, Imperial College, London, UK
Restricted access

Abstract

Use of stem cells may transform the medical therapy for acute and chronic heart disease, with a predictable impact rivalling the results of revascularization and device therapies. Many cell types have been studied recently, and promising preclinical and clinical data are available on their efficacy and safety in the setting of various disorders such as arrhythmia and conduction disease. However, there are still many hurdles to be tackled for the routine clinical application of these cells. A better understanding of the biology of stem cells will help in the design of future strategies.

  • 1. I.H. Park N. Arora H. Huo N. Maherali T. Ahfeldt A. Shimamura M.W. Lensch C. Cowan K. Hochedlinger G.Q. Daley 2008 Disease-specific induced pluripotent stem cells Cell 134 877 886.

    • Search Google Scholar
    • Export Citation
  • 2. A. Moretti M. Bellin A. Welling C.B. Jung J.T. Lam L. Bott-Flugel T. Dorn A. Goedel C. Hohnke F. Hofmann M. Seyfarth D. Sinnecker A. Schomig K.L. Laugwitz 2010 Patient-specific induced pluripotent stem-cell models for long-QT syndrome N Engl J Med 363 1397 1409.

    • Search Google Scholar
    • Export Citation
  • 3. I. Itzhaki L. Maizels I. Huber L. Zwi-Dantsis O. Caspi A. Winterstern O. Feldman A. Gepstein G. Arbel H. Hammerman M. Boulos L. Gepstein 2011 Modelling the long QT syndrome with induced pluripotent stem cells Nature 471 225 229.

    • Search Google Scholar
    • Export Citation
  • 4. S.H. Abdul Kadir N.N. Ali M. Mioulane M. Brito-Martins S. Abu-Hayyeh G. Foldes A.V. Moshkov C. Williamson S.E. Harding J. Gorelik 2009 Embryonic stem cell-derived cardiomyocytes as a model to study fetal arrhythmia related to maternal disease J Cell Mol Med 13 3730 3741.

    • Search Google Scholar
    • Export Citation
  • 5. T. Xue H.C. Cho F.G. Akar S.Y. Tsang S.P. Jones E. Marban G.F. Tomaselli R.A. Li 2005 Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers Circulation 111 11 20.

    • Search Google Scholar
    • Export Citation
  • 6. I. Kehat L. Khimovich O. Caspi A. Gepstein R. Shofti G. Arbel I. Huber J. Satin J. Itskovitz-Eldor L. Gepstein 2004 Electromechanical integration of cardiomyocytes derived from human embryonic stem cells Nat Biotechnol 22 1282 1289.

    • Search Google Scholar
    • Export Citation
  • 7. I. Potapova A. Plotnikov Z. Lu P. Danilo Jr. V. Valiunas J. Qu S. Doronin J. Zuckerman I.N. Shlapakova J. Gao Z. Pan A.J. Herron R.B. Robinson P.R. Brink M.R. Rosen I.S. Cohen 2004 Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers Circ Res 94 952 959.

    • Search Google Scholar
    • Export Citation
  • 8. A.N. Plotnikov E.A. Sosunov J. Qu I.N. Shlapakova E.P. Anyukhovsky L. Liu M.J. Janse P.R. Brink I.S. Cohen R.B. Robinson P. Danilo Jr. M.R. Rosen 2004 Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates Circulation 109 506 512.

    • Search Google Scholar
    • Export Citation
  • 9. W.Z. Zhu Y. Xie K.W. Moyes J.D. Gold B. Askari M.A. Laflamme 2010 Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells Circ Res 107 776 786.

    • Search Google Scholar
    • Export Citation
  • 10. H.S. Chen C. Kim M. Mercola 2009 Electrophysiological challenges of cell-based myocardial repair Circulation 120 2496 2508.

  • 11. Y.M. Zhang C. Hartzell M. Narlow S.C. Dudley Jr. 2002 Stem cell-derived cardiomyocytes demonstrate arrhythmic potential Circulation 106 1294 1299.

    • Search Google Scholar
    • Export Citation
  • 12. R. Passier L.W. van Laake C.L. Mummery 2008 Stem-cell-based therapy and lessons from the heart Nature 453 322 329.

  • 13. P. Menasche 2009 Stem cell therapy for heart failure: are arrhythmias a real safety concern? Circulation 119 2735 2740.

  • 14. P. Menasche O. Alfieri S. Janssens W. McKenna H. Reichenspurner L. Trinquart J.T. Vilquin J.P. Marolleau B. Seymour J. Larghero S. Lake G. Chatellier S. Solomon M. Desnos A.A. Hagege 2008 TheMyoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation Circulation 117 1189 1200.

    • Search Google Scholar
    • Export Citation
  • 15. S. Fernandes J.C. Amirault G. Lande J.M. Nguyen V. Forest O. Bignolais G. Lamirault D. Heudes J.L. Orsonneau M.F. Heymann F. Charpentier P. Lemarchand 2006 Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias Cardiovasc Res 69 348 358.

    • Search Google Scholar
    • Export Citation

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Oct 2020 0 0 0
Nov 2020 3 0 0
Dec 2020 1 0 0
Jan 2021 1 1 1
Feb 2021 0 0 0
Mar 2021 1 0 0
Apr 2021 1 0 0